Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.66 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALPG | P10696 | 2/20 | 0.39 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | NMT1 | P30419 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 5/20 | 0.37 |
| ▸ | RAB9A | P51151 | 5/20 | 0.37 |
| ▸ | HTT | P42858 | 4/20 | 0.37 |
| ▸ | GALR3 | O60755 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4230750 | 1.00 | TLR8 (0.66) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| SCHEMBL11531858 | 1.00 | TLR8 (0.66) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| SCHEMBL902006 | 1.00 | TLR8 (0.66) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| SCHEMBL6889380 | 1.00 | TLR8 (0.66) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| Hydrochloric Acid SCHEMBL29272024 | 0.98 | TLR8 (0.67) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| Bromide SCHEMBL28568345 | 0.98 | TLR8 (0.64) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| Hydrochloric Acid SCHEMBL10768898 | 0.98 | TLR8 (0.67) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| SCHEMBL4227901 | 0.98 | TLR8 (0.68) | TLR8POLBALDH1A1KMT2ATBXAS1 | |
| SCHEMBL329466 | 0.92 | ALDH1A1 (0.63) | TLR8POLBALDH1A1KMT2AALPG | |
| Iodide SCHEMBL4267902 | 0.91 | ALDH1A1 (0.61) | TLR8POLBALDH1A1KMT2AALPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007149842-A2 | METHOD OF PREPARING IMIDAZOLIUM SURFACTANTS | BRIDGESTONE CORPORATION (JP) | 2007-12-27 | — | — | WO | claimed |
| US-20070293684-A1 | Method of preparing imidazolium surfactants | BRIDGESTONE CORPORATION | 2007-12-20 | — | — | US | claimed |
| US-7935184-B2 | Method of preparing imidazolium surfactants | BRIDGESTONE CORPORATION (JP) | 2011-05-03 | — | — | US | disclosed |
| WO-2007149842-A2 | METHOD OF PREPARING IMIDAZOLIUM SURFACTANTS | BRIDGESTONE CORPORATION (JP) | 2007-12-27 | — | — | WO | disclosed |
| US-20070293684-A1 | Method of preparing imidazolium surfactants | BRIDGESTONE CORPORATION | 2007-12-20 | — | — | US | disclosed |
| EP-0690894-A1 | PAINTS CONTAINING n-ALKYL-N-AZOLS AS PRESERVATIVES | BAYER AG (DE) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994021734-A1 | PAINTS CONTAINING n-ALKYL-N-AZOLS AS PRESERVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1994-09-29 | — | — | WO | disclosed |
| WO-1991019699-A1 | A PROCESS FOR PREPARING 1-ALKYLIMIDAZOLES | COGNIS, INCORPORATED (US) | 1991-12-26 | — | — | WO | disclosed |
| US-4140518-A | IMIDAZOLE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-20 | — | — | US | disclosed |
| US-4062965-A | Quaternary imidazole compounds as microbicides | TH. GOLDSCHMIDT AG (DT) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293684-A1 | Method of preparing imidazolium surfactants | SMARCC2, SMARCC1, ITPR3 | TLR8 1985/4885POLB 1460/4885ALDH1A1 4774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.